Busey Bank’s AbbVie ABBV Stock Holding History

Busey Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.6M	Sell	76,483 -2,446	-3%	-$543K	0.45%	59
2025 Q4	$18M	Sell	78,929 -1,379	-2%	-$314K	0.48%	51
2025 Q3	$18.6M	Buy	80,308 +16	+0%	+$3.26K	0.52%	48
2025 Q2	$14.9M	Sell	80,292 -344	-0.4%	-$63.9K	0.45%	57
2025 Q1	$16.9M	Sell	80,636 -1,156	-1%	-$225K	0.57%	44
2024 Q4	$14.5M	Sell	81,792 -708	-0.9%	-$130K	0.48%	55
2024 Q3	$16.3M	Sell	82,500 -90	-0.1%	-$16.8K	0.53%	54
2024 Q2	$14.2M	Sell	82,590 -1,426	-2%	-$236K	0.48%	58
2024 Q1	$15.3M	Sell	84,016 -2,107	-2%	-$363K	0.54%	54
2023 Q4	$13.3M	Buy	86,123 +17,234	+25%	+$2.51M	0.51%	58
2023 Q3	$10.3M	Sell	68,889 -5,103	-7%	-$749K	0.44%	68
2023 Q2	$9.97M	Sell	73,992 -775	-1%	-$114K	0.41%	70
2023 Q1	$11.9M	Sell	74,767 -1,875	-2%	-$287K	0.5%	59
2022 Q4	$12.4M	Sell	76,642 -1,377	-2%	-$211K	0.56%	52
2022 Q3	$10.5M	Sell	78,019 -777	-1%	-$111K	0.52%	55
2022 Q2	$12.1M	Sell	78,796 -3,289	-4%	-$503K	0.56%	47
2022 Q1	$13.3M	Sell	82,085 -2,354	-3%	-$342K	0.53%	52
2021 Q4	$11.4M	Sell	84,439 -2,321	-3%	-$274K	0.43%	65
2021 Q3	$9.36M	Buy	86,760 +37,869	+77%	+$4.33M	0.38%	73
2021 Q2	$5.51M	Buy	48,891 +1,481	+3%	+$167K	0.26%	93
2021 Q1	$5.13M	Buy	47,410 +596	+1%	+$63.8K	0.26%	94
2020 Q4	$5.02M	Sell	46,814 -784	-2%	-$75.3K	0.29%	91
2020 Q3	$4.17M	Sell	47,598 -676	-1%	-$63.6K	0.27%	91
2020 Q2	$4.74M	Sell	48,274 -8,412	-15%	-$741K	0.33%	79
2020 Q1	$4.32M	Sell	56,686 -59	-0.1%	-$5.03K	0.35%	77
2019 Q4	$5.03M	Buy	56,745 +117	+0.2%	+$9.71K	0.33%	88
2019 Q3	$4.29M	Buy	56,628 +19,910	+54%	+$1.37M	0.31%	87
2019 Q2	$2.67M	Sell	36,718 -926	-2%	-$72.8K	0.25%	86
2019 Q1	$3.03M	Buy	37,644 +153	+0.4%	+$12.5K	0.28%	80
2018 Q4	$3.46M	Sell	37,491 -325	-0.9%	-$28.6K	0.36%	72
2018 Q3	$3.58M	Buy	37,816 +947	+3%	+$89.8K	0.33%	72
2018 Q2	$3.42M	Buy	36,869 +644	+2%	+$62.9K	0.34%	77
2018 Q1	$3.43M	Buy	36,225 +141	+0.4%	+$15.5K	0.36%	75
2017 Q4	$3.49M	Buy	36,084 +8,038	+29%	+$758K	0.45%	68
2017 Q3	$2.49M	Sell	28,046 -65	-0.2%	-$4.95K	0.3%	79
2017 Q2	$2.04M	Buy	28,111 +1,280	+5%	+$86.1K	0.28%	77
2017 Q1	$1.75M	Buy	26,831 +202	+0.8%	+$12.7K	0.21%	84
2016 Q4	$1.67M	Sell	26,629 -2,642	-9%	-$161K	0.21%	85
2016 Q3	$1.85M	Sell	29,271 -2,622	-8%	-$170K	0.24%	82
2016 Q2	$1.98M	Buy	31,893 +2,033	+7%	+$124K	0.25%	82
2016 Q1	$1.71M	Buy	29,860 +166	+0.6%	+$9.25K	0.23%	91
2015 Q4	$1.76M	Sell	29,694 -510	-2%	-$29.4K	0.23%	90
2015 Q3	$1.64M	Sell	30,204 -1,598	-5%	-$104K	0.23%	88
2015 Q2	$2.14M	Sell	31,802 -447	-1%	-$29.2K	0.29%	87
2015 Q1	$1.89M	Sell	32,249 -442	-1%	-$26.7K	0.26%	92
2014 Q4	$2.14M	Sell	32,691 -326	-1%	-$20.6K	0.29%	84
2014 Q3	$1.91M	Buy	33,017 +7,852	+31%	+$436K	0.28%	84
2014 Q2	$1.42M	Buy	25,165 +339	+1%	+$17.8K	0.2%	81
2014 Q1	$1.28M	Sell	24,826 -1,200	-5%	-$60.6K	0.19%	78
2013 Q4	$1.38M	Buy	26,026 +3,818	+17%	+$188K	0.21%	73
2013 Q3	$994K	Sell	22,208 -198	-0.9%	-$8.78K	0.16%	71
2013 Q2	$926K	Buy	+22,406	New	+$980K	0.16%	71

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Busey Bank's ABBV Position: Q1 2026 in Review

Busey Bank reduced its AbbVie (ABBV) stake by 3.1% in Q1 2026, selling an estimated $543K and leaving 76,483 shares worth $16.6M. The position accounts for 0.45% of the portfolio, ranked #59.

Busey Bank first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.6M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Busey Bank held 76,483 shares of AbbVie worth $16.6M as of Q1 2026.
Busey Bank sold 2,446 AbbVie shares in Q1 2026, an estimated $543K.
AbbVie made up 0.45% of Busey Bank's portfolio in Q1 2026, its #59 holding.
Busey Bank first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Busey Bank's AbbVie position peaked at $18.6M in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Busey Bank's 13F filing for Q1 2026, filed 28 Apr 2026.